Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibroblast Growth Factor 23”

108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 108 results

Large-scale testing (Phase 3)Study completedNCT03920072
What this trial is testing

Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd 35
Not applicableStudy completedNCT03173235
What this trial is testing

Plasma Concentrations of Calcium, Phosphate, FGF23, Klotho, 25 (OH) D3 and 1,25 (OH) 2D3 from Patients Who Wants to Have Children

Who this might be right for
Infertility, Female
University Hospital Tuebingen 80
Not applicableUnknownNCT01971619
What this trial is testing

Association of Vitamin D, Parathyroid Hormone and Fibroblast Growth Factor-23 With Infarction-related Arrhythmia in Patients With Acute Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Yonsei University 510
Large-scale testing (Phase 3)Study completedNCT01220843
What this trial is testing

FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease

Who this might be right for
Chronic Renal Failure
Centre Hospitalier Universitaire, Amiens 98
Not applicableUnknownNCT02331966
What this trial is testing

Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia

Who this might be right for
Tumor Induced Oncogenic Osteomalacia
AHEPA University Hospital 10
Post-approval studies (Phase 4)Study completedNCT01738945
What this trial is testing

Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose

Who this might be right for
We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.
Gulhane School of Medicine 32
Not applicableStudy completedNCT03771924
What this trial is testing

Postprandial Response of Individuals to Dietary Inorganic Phosphate

Who this might be right for
Cardiovascular Risk Factor
Martin-Luther-Universität Halle-Wittenberg 29
Not applicableStudy completedNCT01180946
What this trial is testing

Vitamin D Deficiency in Adolescent Girls

Who this might be right for
HealthyVitamin D Deficiency
Massachusetts General Hospital 90
Large-scale testing (Phase 3)Study completedNCT02537431
What this trial is testing

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 14
Post-approval studies (Phase 4)Study completedNCT05357573
What this trial is testing

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO

Who this might be right for
Tumor-Induced Osteomalacia (TIO)
Kyowa Kirin Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT03581591
What this trial is testing

Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets

Who this might be right for
HypophosphatemiaHypophosphatemic RicketsPain, Chronic
Redwood Dermatology Sciences 1
Not applicableLooking for participantsNCT07183579
What this trial is testing

Effective Dosing of Burosumab in XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
University of Nottingham 120
Post-approval studies (Phase 4)Study completedNCT01703234
What this trial is testing

FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients

Who this might be right for
ProteinuriaDiabetic NephropathyChronic Kidney Disease
Gulhane School of Medicine 78
Not applicableStudy completedNCT02830464
What this trial is testing

New Biomarkers in Heart- and Renal Failure

Who this might be right for
Heart FailureKidney Failure
RWTH Aachen University 500
Not applicableStudy completedNCT01801501
What this trial is testing

Role of FGF-23 as a Prognosis Biomarker in Intensive Care Patients

Who this might be right for
SepsisAcute Kidney Injury
University of Chile 164
Not applicableTemporarily pausedNCT03193073
What this trial is testing

Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient

Who this might be right for
Anemia of Chronic Kidney DiseaseEndothelial DysfunctionLeft Ventricular Hypertrophy+1 more
Omnia Mohammed Hashem 80
Not applicableUnknownNCT03821922
What this trial is testing

Fibroblast Growth Factor 23 and Hypertensive Disorder Complicating Pregnancy

Who this might be right for
Hypertension, Pregnancy-Induced
First Affiliated Hospital, Sun Yat-Sen University 300
Early research (Phase 1)Active Not RecruitingNCT02891954
What this trial is testing

Genetics of Response to Canagliflozin

Who this might be right for
Diabetes Mellitus, Type 2
University of Maryland, Baltimore 700
Not applicableUnknownNCT01526304
What this trial is testing

The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers

Who this might be right for
Kidney Stones
University of Zurich 150
Not applicableWithdrawnNCT00305279
What this trial is testing

The Effects of Dietary Phosphate Intake on Calciotropic Hormones and FGF23.

Who this might be right for
HealthyKidney Failure, Chronic
University of California, San Francisco
Load More Results